Alaris Royalty (ALARF) 26.5348 $ALARF Alaris Royalty'

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

AI's Impact on Trading: Key Developments and Insights In recent years, artificial intelligence (AI) has significantly influenced various industries, and trading is no exception. FBS, a prominent global broker, has conducted a deep dive into this revolutionary shift. They emphasize how AI is enhancing the efficiency, accuracy, and overall decision-making processes in...

Insights into Alerus Financial Corp’s Upcoming Earnings Alerus Finl (NASDAQ: ALRS) is gearing up to share its quarterly earnings report on a forthcoming Monday. Investors are on the edge of their seats, eagerly anticipating insights into the company’s performance and forecasts for the upcoming quarter. Analysts predict that Alerus Finl will achieve an earnings per...

DXC Technology Unveils New Customer Experience Center in London DXC Technology (NYSE: DXC), a prominent enterprise technology partner, has recently inaugurated its Customer Experience Center in London. This center is set to transform how businesses harness artificial intelligence (AI) by assisting them in moving from merely experimenting with AI technologies to achieving...

Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT Coave Therapeutics, a leader in genetic medicine innovation, recently presented compelling data regarding its advanced suprachoroidal capsid, coAAV-SCS-01, at the European Society of Gene and Cell Therapy Congress 2025 held in Seville. This innovative capsid has shown to outperform traditional capsids,...

HealthPRO Canada's Continued Commitment to Excellence HealthPRO Canada, a prominent provider of group contracting for healthcare, proudly announces its status as a Great Place to Work® for the fourth consecutive year. This recognition highlights the organization’s dedication to fostering a supportive and inclusive work environment. Understanding the Great Place to...